EUVIMEDEUVIMED entdecken
Crossref

Clinical and epidemiological features and severity markers in children admitted with multisystem inflammatory syndrome in children (MISC) in a tertiary care center in the United Arab Emirates

Habiba H AboAlEla, Abdulrahman Y Ali iD, Ghadah A Al-Sharif, Walid Abuhammour, Ahmad Abou Tayoun, Mohammad Almoosa, Diego Arango Uribe, Ali Al-Fraihat iD, Samuel B Ho, Amar H Khamis, Rizwana Popatia iD, Lemis Yavuz

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Habiba H AboAlEla und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates. Hauptthemen laut MEDLINE: Systemic Inflammatory Response Syndrome, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Al Jalila Foundation, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multisystem inflammatory syndrome in children (MISC) is a phenomenon that appeared in children infected with or exposed to severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2). The typical onset of MISC is 4−6 weeks following SARS‐CoV‐2 infection and is formulated to be due to an immune response.

Methods

Our study retrospectively analyzed data from a tertiary center in United Arab Emirates of MISC patients who were admitted to either general pediatric wards or pediatric intensive care (PICU) or who came exclusively for follow‐up (post‐PICU admission) from May 2020 to August 2021.

Results

The total sample size was 50 patients, and the study included a comparison of MISC‐PICU admissions with MISC‐non‐PICU admissions. The MISC‐PICU sample size was 18 patients, 50% females, with mean age of 8.3 years all were previously healthy. MISC‐PICU patients had deranged blood counts with a lower hemoglobin count, a more pronounced lymphopenia and thrombocytopenia along with hypoalbuminemia. MISC‐PICU patients presented with relatively higher inflammatory markers: C‐reactive protein, procalcitonin, ferritin, and d ‐dimer. Immunological studies were significantly higher for interleukin‐6 levels in PICU patients. On echocardiography, higher myocardial dysfunction was more notable in MISC‐PICU patients. Likewise, MISC‐PICU patients were provided with more extensive therapy. As part of our study course, we reevaluated our MISC‐PICU patients twice, once at 48 h post‐PICU admission and again 4−6 weeks after discharge from the hospital. No deaths have been recorded in the cohort.

Conclusion

This study evaluated risk factors of MISC and potential severity features. Follow‐up of patients on discharge showed improvement across all domains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Systemic Inflammatory Response SyndromeCOVID-19HumansUnited Arab EmiratesFemaleMaleChildRetrospective StudiesTertiary Care CentersChild, PreschoolBiomarkersSeverity of Illness IndexIntensive Care Units, PediatricAdolescentInfantHospitalizationSARS-CoV-2

Stichwörter der Autor:innen

COVID-19MISCPICUSARS-COV2childrenclinical featurespediatrics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
  • Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.
  • Department of Medicine, Mediclinic City Hospital, Dubai, United Arab Emirates.
  • Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
  • Amana Healthcare, Dubai, United Arab Emirates.

ORCID-Profile: Abdulrahman Y Ali, Ali Al-Fraihat, Rizwana Popatia

Förderung

  • Al Jalila Foundation
  • Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE

Zitieren

APA

AboAlEla, H. H., Ali, A. Y., Al-Sharif, G. A., Abuhammour, W., Tayoun, A. A., Almoosa, M., Uribe, D. A., Al-Fraihat, A., Ho, S. B., Khamis, A. H., Popatia, R., & Yavuz, L. (2023). Clinical and epidemiological features and severity markers in children admitted with multisystem inflammatory syndrome in children (MISC) in a tertiary care center in the United Arab Emirates. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26614

Vancouver

AboAlEla HH, Ali AY, Al-Sharif GA, Abuhammour W, Tayoun AA, Almoosa M, et al. Clinical and epidemiological features and severity markers in children admitted with multisystem inflammatory syndrome in children (MISC) in a tertiary care center in the United Arab Emirates. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26614

BibTeX
@article{AboAlEla2023,
  author = {AboAlEla, Habiba H and Ali, Abdulrahman Y and Al-Sharif, Ghadah A and Abuhammour, Walid and Tayoun, Ahmad Abou and Almoosa, Mohammad and Uribe, Diego Arango and Al-Fraihat, Ali and Ho, Samuel B and Khamis, Amar H and Popatia, Rizwana and Yavuz, Lemis},
  title = {Clinical and epidemiological features and severity markers in children admitted with multisystem inflammatory syndrome in children (MISC) in a tertiary care center in the United Arab Emirates},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26614}
}
Kostenlos starten →